评估儿童严重耐疗性喘:诊断和治疗策略
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.
优化喘管理是关键,特别是在严重的病例中. 虽然新的生物疗法为治疗耐药性喘提供了希望,但对于大多数患者来说,掌握基础治疗仍然至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床药理学 临床药理学
背景情况:
- 喘是一种普遍存在的全球呼吸道疾病,导致严重的发病率.
- 对于大多数喘患者来说,有效的治疗依赖于正确和定期使用药物.
- 大约10%的喘患者患有无法控制的疾病或需要高剂量的药物,导致高医疗费用.
研究的目的:
- 审查严重喘的定义,管理和药物治疗.
- 讨论世界卫生组织 (WHO) 对严重喘的分类及其治疗水平.
- 概述管理难以治疗喘患者的策略.
主要方法:
- 在PubMed的文献搜索和个人档案中进行严重喘研究.
- 世界卫生组织对严重喘的分类和治疗指南的分析.
- 对优化基本喘管理的多学科团队评估协议的审查.
主要成果:
- 许多转诊高级治疗的患者在多学科评估后,可以通过优化的标准治疗来管理.
- 对于真正的耐治疗喘,选择包括针对2型炎症的单克隆抗体.
- 在理解和治疗非酸性严重喘方面仍然存在重大差距.
结论:
- 正确实施基础性喘护理至关重要.
- 生物疗法,如单克隆抗体,代表了严重的治疗耐药喘的重大进展.
- 需要进一步的研究,以解决非酸性喘的有限治疗选择.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
相关概念视频
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
